TACTILE SYSTEMS TECHNOLOGY Business Summary

Tactile Systems Technology Inc. (TCMD), operating as Tactile Medical, generates revenue primarily through the sale and rental of proprietary medical devices designed for at-home treatment of chronic conditions. The company’s business is bifurcated into two core segments: Lymphedema, which includes the Flexitouch Plus and the portable Nimbl platform for pneumatic compression, and Airway Clearance, centered on the AffloVest for respiratory disorders. Revenue is driven by a high-touch, direct-to-patient sales model supported by deep reimbursement expertise and a robust intellectual property portfolio. Tactile Medical maintains a dominant leadership position in the U.S. pneumatic compression therapy market, competing directly with specialized manufacturers such as Electromed, Inc., Bio Compression Systems, and Mego Afek Ltd. While larger med-tech firms like Inspire Medical Systems are often cited as industry peers, Tactile differentiates itself through its specialized focus on the underserved lymphatic and pulmonary home-care niches. Founded in 1995 by Irene Waldridge, who pioneered the company’s first pneumatic compression prototypes, Tactile Medical is currently led by CEO Sheri Dodd, a healthcare veteran who joined in July 2024 after serving as President of Medtronic Canada and holding senior leadership roles at Johnson & Johnson and the World Health Organization. The executive team includes CFO Elaine Birkemeyer, formerly of Optum and Best Buy, and Chief Medical Officer Dr. Antonios Gasparis, a renowned vascular surgeon. The board is chaired by William W. Burke and features strategic directors like former CEO Dan Reuvers and recent appointee Laura King, a former GE Healthcare executive. The company’s institutional pedigree is bolstered by significant ownership from top-tier investors including The Vanguard Group, BlackRock, and Morgan Stanley, signaling strong market confidence in its expansion into chronic at-home therapy.